33
https://pubmed.ncbi.nlm.nih.gov/38115193
Mandating reimbursement for non-FDA-regulated cannabis products is a public health risk and should not be implemented without thorough studies on their safety.
“Opposing Mandatory Reimbursement for Unregulated Cannabis Products: A Public Health Concern”
